ocr: Figure 2 Estimated Probability of a Patient Responding to Migranalo dinydroergotamine mesylale, USP) Nasal Spray 100 During the Four Hours Following Dosing" 90 Studies 3 and 4 (Migranal N=97, Placebo N=100) 80 - l 70 2 0 60 la 3 - 3 50 8 l Migranako 40 30 le - Placebo - - - 20 e - 10 1 - - - L - - - - - - - - - 0.5 1 2 3 Time From First Dose (HRs) *The figure shows the probability over time of obtaining a response following treatment with Migranale dinydroergotamine mesylate, USP) Nasal Spray. Headache esponse was evaluated on a five-point scale that confounded pain response and restoration of ...
